Since we observed that serum IL-23 levels correlated positively with cytoplasmic Sirt1 activity in PBMCs isolated from RA patients, we cannot exclude that cathepsins could be involved in the degradation of Sirt1 mediated by IL-23, thereby providing a negative feed-back loop. This evidence concerns the gene IL37 and rheumatoid arthritis.